MERCK SERONO LIMITED
Reference: GB-PPON-PYQR-6988-GHRW
35
Awards
€967,293,495
Total awarded
Recent awards
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
- NHS Framework Agreement for South of England Branded - Tranche B and Annual
- NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual
- Interferon Beta-1a (Rebif®)
- Cladribine (Mavenclad®)
- NP91618d Interferon Beta-1a (Rebif®)
- NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
- NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.